CN103420938A - 一种在制备喹诺酮药物中缩哌反应后回收哌嗪的方法 - Google Patents
一种在制备喹诺酮药物中缩哌反应后回收哌嗪的方法 Download PDFInfo
- Publication number
- CN103420938A CN103420938A CN201210171626XA CN201210171626A CN103420938A CN 103420938 A CN103420938 A CN 103420938A CN 201210171626X A CN201210171626X A CN 201210171626XA CN 201210171626 A CN201210171626 A CN 201210171626A CN 103420938 A CN103420938 A CN 103420938A
- Authority
- CN
- China
- Prior art keywords
- piperazine
- quinolone
- reaction
- alcohol
- mineral alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title claims abstract description 162
- 238000000034 method Methods 0.000 title claims abstract description 39
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 238000006482 condensation reaction Methods 0.000 title abstract 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 21
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000003513 alkali Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 13
- 239000011707 mineral Substances 0.000 claims description 13
- 235000010755 mineral Nutrition 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 229960003405 ciprofloxacin Drugs 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 6
- XBHBWNFJWIASRO-UHFFFAOYSA-N 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C=C1 XBHBWNFJWIASRO-UHFFFAOYSA-N 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 5
- 229950007734 sarafloxacin Drugs 0.000 claims description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 235000017550 sodium carbonate Nutrition 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 238000011084 recovery Methods 0.000 abstract description 19
- -1 alkali metal salt Chemical class 0.000 abstract description 7
- 238000005265 energy consumption Methods 0.000 abstract description 5
- 229910052783 alkali metal Inorganic materials 0.000 abstract description 4
- 238000009835 boiling Methods 0.000 abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 230000003993 interaction Effects 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000002351 wastewater Substances 0.000 abstract description 2
- 230000007423 decrease Effects 0.000 abstract 2
- 239000007789 gas Substances 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 238000000227 grinding Methods 0.000 description 7
- 125000004193 piperazinyl group Chemical group 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000012492 regenerant Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 150000007660 quinolones Chemical class 0.000 description 6
- 230000000630 rising effect Effects 0.000 description 6
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 description 5
- IRWJAZYCWCBIOU-UHFFFAOYSA-N 6-chloro-1-cyclopropyl-4-oxoquinoline-3-carboxylic acid Chemical compound C12=CC=C(Cl)C=C2C(=O)C(C(=O)O)=CN1C1CC1 IRWJAZYCWCBIOU-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical compound C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 description 2
- 239000002912 waste gas Substances 0.000 description 2
- XZSWHQCDTYJZJA-UHFFFAOYSA-N 5-(methylamino)pyridine-3-carboxylic acid Chemical compound CNC1=CN=CC(C(O)=O)=C1 XZSWHQCDTYJZJA-UHFFFAOYSA-N 0.000 description 1
- YVRGGPBWRTYCDP-UHFFFAOYSA-N 6-chloro-1-ethyl-4-oxoquinoline-3-carboxylic acid Chemical compound ClC1=CC=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 YVRGGPBWRTYCDP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010054814 DNA Gyrase Proteins 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- MSQACBWWAIBWIC-UHFFFAOYSA-N hydron;piperazine;chloride Chemical compound Cl.C1CNCCN1 MSQACBWWAIBWIC-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210171626.XA CN103420938B (zh) | 2012-05-25 | 2012-05-25 | 一种在制备喹诺酮药物中缩哌反应后回收哌嗪的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210171626.XA CN103420938B (zh) | 2012-05-25 | 2012-05-25 | 一种在制备喹诺酮药物中缩哌反应后回收哌嗪的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103420938A true CN103420938A (zh) | 2013-12-04 |
CN103420938B CN103420938B (zh) | 2015-07-29 |
Family
ID=49646364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210171626.XA Active CN103420938B (zh) | 2012-05-25 | 2012-05-25 | 一种在制备喹诺酮药物中缩哌反应后回收哌嗪的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103420938B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109232528A (zh) * | 2018-09-11 | 2019-01-18 | 河南精康制药有限公司 | 一种司帕沙星缩合母液的高效回收利用方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1321121C (zh) * | 2005-04-21 | 2007-06-13 | 浙江医药股份有限公司新昌制药厂 | 左氧氟沙星制备及后处理方法 |
CN101514208A (zh) * | 2008-10-17 | 2009-08-26 | 浙江京新药业股份有限公司 | 氧氟沙星的绿色合成工艺 |
CN101768167A (zh) * | 2010-01-15 | 2010-07-07 | 浙江东亚药业有限公司 | 左氧氟沙星的新缩哌合成方法 |
CN101781313A (zh) * | 2010-03-05 | 2010-07-21 | 浙江京新药业股份有限公司 | 喹诺酮类药物的合成方法 |
CN101851198A (zh) * | 2009-03-31 | 2010-10-06 | 浙江京新药业股份有限公司 | 盐酸环丙沙星的制备方法 |
CN101565428B (zh) * | 2009-06-02 | 2011-06-29 | 重庆科瑞制药有限责任公司 | 普卢利沙星的制备方法 |
-
2012
- 2012-05-25 CN CN201210171626.XA patent/CN103420938B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1321121C (zh) * | 2005-04-21 | 2007-06-13 | 浙江医药股份有限公司新昌制药厂 | 左氧氟沙星制备及后处理方法 |
CN101514208A (zh) * | 2008-10-17 | 2009-08-26 | 浙江京新药业股份有限公司 | 氧氟沙星的绿色合成工艺 |
CN101851198A (zh) * | 2009-03-31 | 2010-10-06 | 浙江京新药业股份有限公司 | 盐酸环丙沙星的制备方法 |
CN101565428B (zh) * | 2009-06-02 | 2011-06-29 | 重庆科瑞制药有限责任公司 | 普卢利沙星的制备方法 |
CN101768167A (zh) * | 2010-01-15 | 2010-07-07 | 浙江东亚药业有限公司 | 左氧氟沙星的新缩哌合成方法 |
CN101781313A (zh) * | 2010-03-05 | 2010-07-21 | 浙江京新药业股份有限公司 | 喹诺酮类药物的合成方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109232528A (zh) * | 2018-09-11 | 2019-01-18 | 河南精康制药有限公司 | 一种司帕沙星缩合母液的高效回收利用方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103420938B (zh) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104910020B (zh) | 从三氯蔗糖生产废水中回收二甲胺的方法 | |
CN102229586B (zh) | 一种α-乙酰基-γ-丁内酯的制备方法 | |
CN105348154A (zh) | 一种多西环素生产废液中磺基水杨酸的回收方法 | |
CN111808016A (zh) | 一种尼拉帕尼中间体(s)-3-(4-溴苯基)哌啶的制备方法 | |
CN110590706B (zh) | 一种n-甲基吡咯烷的制备方法 | |
CN103420938B (zh) | 一种在制备喹诺酮药物中缩哌反应后回收哌嗪的方法 | |
CN104058936A (zh) | 一种分离提纯对甲酚的方法 | |
CN112321543A (zh) | 一种α-氯代-α乙酰基-γ-丁内酯的制备方法 | |
CN102120717B (zh) | 以氯苯为溶剂生产三氯甲氧基苯的方法 | |
CN108623580A (zh) | 莫西沙星侧链及其中间体的制备方法 | |
CN105330545A (zh) | 以氯化锡为催化剂回收三嗪环环合母液渣子中草酸的方法 | |
CN106631991B (zh) | 一种n-丁基-2,2,6,6-四甲基-4-哌啶胺的简便合成方法 | |
CN107721815A (zh) | 一种合成2‑(3,5‑二(三氟甲基)苯基)‑2‑甲基丙酸的制备方法 | |
CN107698630A (zh) | 一种三苄糖苷的制备方法 | |
CN106748826B (zh) | N,n,n’-三甲基-n’-羟乙基-乙二胺的制备法 | |
CN103467268B (zh) | 一种2,2′-二羟基-4,4′-二甲氧基二苯甲酮的制备方法 | |
CN106748808A (zh) | 一种2,6‑二氯对硝基苯胺的环保制备方法 | |
CN113443986A (zh) | 一种合成3-氧代-1-环丁烷羧酸的中间体的制备方法 | |
CN101343230B (zh) | 2,4-二硝基苯酚阻聚剂的纯化方法 | |
CN113880693B (zh) | 一种多组分溶剂中三氟乙醇回收的方法 | |
CN114349635B (zh) | 一种度鲁特韦核心中间体的合成方法 | |
CN104671219A (zh) | 一种硫酰氯分离提纯工艺 | |
CN108164428B (zh) | 一种三(2-氯乙基)胺盐酸盐的制备方法 | |
CN113149855B (zh) | 一种11α-氯代甲烯土霉素对甲苯磺酸盐的合成方法 | |
CN113402402B (zh) | 低浓度废液回收反式-对氨基环己醇的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 800, East Xinchang Avenue, Yulin street, Xinchang County, Shaoxing City, Zhejiang Province 312500 Patentee after: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region after: China Patentee after: Shaoxing Jingxin Pharmaceutical Co.,Ltd. Address before: No. 800, East Xinchang Avenue, Yulin street, Xinchang County, Shaoxing City, Zhejiang Province 312500 Patentee before: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region before: China Patentee before: SHANGYU JINGXIN PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |